Clinical features and outcomes in adults with COVID-19 during the pre-Omicron and Omicron waves.

COVID-19 Mortality Nosocomial cases Outcome SARS-CoV-2 variants

Journal

Infectious diseases now
ISSN: 2666-9919
Titre abrégé: Infect Dis Now
Pays: France
ID NLM: 101775152

Informations de publication

Date de publication:
14 Nov 2023
Historique:
received: 26 06 2023
revised: 07 11 2023
accepted: 13 11 2023
pubmed: 17 11 2023
medline: 17 11 2023
entrez: 16 11 2023
Statut: aheadofprint

Résumé

We conducted a single-center retrospective study to compare patient characteristics and death rates during the Omicron (O, December 01, 2021, to September 30, 2022) and pre-Omicron (PO, March 01, 1920, to October 31, 2021) periods. We retrospectively analyzed the data of 2932 patients (1242 (O) and 1690 (PO)) hospitalized (>24 h) with laboratory-confirmed COVID. Compared to the PO period, O period patients were less frequently men, had a lower body mass index and fewer comorbidities except for immunosuppression and pregnancy. Nosocomial COVID-19 accounted for 18.2 % (O) and 15.4 % (PO) of cases (p = 0.05). Patient mortality rates during the O and PO periods were 11.0 % and 16.9 % (p < 0.001), respectively. Unvaccinated status (p < 0.001), existence of comorbidities, (p < 0.001) and high LDH value at baseline (p = 0.015), but not the period, were identified as factors likely to explain death. During the Omicron period, the inpatient death rate remained > 10 %, especially among unvaccinated and comorbid patients. Nosocomial cases were more frequent.

Identifiants

pubmed: 37972817
pii: S2666-9919(23)00195-1
doi: 10.1016/j.idnow.2023.104833
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

104833

Informations de copyright

Copyright © 2023 Elsevier Masson SAS. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

M Martinot (M)

Infectious Disease Department, Hôpitaux Civils de Colmar, Colmar, France. Electronic address: martin.martinot@ch-colmar.fr.

A Schieber (A)

Clinical Research Department, Hôpitaux Civils de Colmar, Colmar, France.

J C Ongagna (JC)

Clinical Research Department, Hôpitaux Civils de Colmar, Colmar, France.

A Henric (A)

Clinical Research Department, Hôpitaux Civils de Colmar, Colmar, France.

M Eyriey (M)

Clinical Research Department, Hôpitaux Civils de Colmar, Colmar, France.

M Mohseni-Zadeh (M)

Infectious Disease Department, Hôpitaux Civils de Colmar, Colmar, France.

C Ion (C)

Infectious Disease Department, Hôpitaux Civils de Colmar, Colmar, France.

K Demesmay (K)

Pharmacy Department, Hôpitaux Civils de Colmar, Colmar, France.

S Gravier (S)

Infectious Disease Department, Hôpitaux Civils de Colmar, Colmar, France.

C Kempf (C)

Clinical Research Department, Hôpitaux Civils de Colmar, Colmar, France.

Classifications MeSH